Literature DB >> 27257716

Driving under the influence of non-alcohol drugs--An update. Part II: Experimental studies.

M C Strand1, H Gjerde1, J Mørland1.   

Abstract

Experimental studies on the impairing effects of drugs of relevance to driving-related performance published between 1998 and 2015 were reviewed. Studies with on-the-road driving, driving simulators, and performance tests were included for benzodiazepines and related drugs, cannabis, opioids, stimulants, GHB, ketamine, antihistamines, and antidepressants. The findings in these experimental studies were briefly discussed in relation to a review of epidemiological studies published recently. The studies mainly concluded that there may be a significant psychomotor impairment after using benzodiazepines or related drugs, cannabis, opioids, GHB, or ketamine. Low doses of central stimulants did not seem to cause impairment of driving behavior.
Copyright © 2016 Central Police University.

Entities:  

Keywords:  Amphetamines; DUID; benzodiazepines; cannabis; cocaine; drugged driving; experimental; hypnotics; impaired driving; impairment; opioids

Mesh:

Substances:

Year:  2016        PMID: 27257716

Source DB:  PubMed          Journal:  Forensic Sci Rev        ISSN: 1042-7201


  18 in total

1.  Prevalence of Self-Reported Prescription Drug Use in a National Sample of U.S. Drivers.

Authors:  Tara Kelley-Baker; Geetha Waehrer; Robin A Pollini
Journal:  J Stud Alcohol Drugs       Date:  2017-01       Impact factor: 2.582

2.  Further evaluation of the potential anxiolytic activity of imidazo[1,5-a][1,4]diazepin agents selective for α2/3-containing GABAA receptors.

Authors:  J M Witkin; R Cerne; M Wakulchik; J S; S D Gleason; T M Jones; G Li; L A Arnold; J-X Li; J M Schkeryantz; K R Methuku; J M Cook; M M Poe
Journal:  Pharmacol Biochem Behav       Date:  2017-04-22       Impact factor: 3.533

3.  Prevalence and motives for drugged driving among emerging adults presenting to an emergency department.

Authors:  Erin E Bonar; Brooke J Arterberry; Alan K Davis; Rebecca M Cunningham; Frederic C Blow; R Lorraine Collins; Maureen A Walton
Journal:  Addict Behav       Date:  2017-11-09       Impact factor: 3.913

4.  Receipt of Warnings Regarding Potentially Impairing Prescription Medications and Associated Risk Perceptions in a National Sample of U.S. Drivers.

Authors:  Robin A Pollini; Geetha Waehrer; Tara Kelley-Baker
Journal:  J Stud Alcohol Drugs       Date:  2017-11       Impact factor: 2.582

Review 5.  Time trends in US cannabis use and cannabis use disorders overall and by sociodemographic subgroups: a narrative review and new findings.

Authors:  Deborah S Hasin; Dvora Shmulewitz; Aaron L Sarvet
Journal:  Am J Drug Alcohol Abuse       Date:  2019-03-14       Impact factor: 3.829

6.  Driving while under the influence of hallucinogens: Prevalence, correlates, and risk profiles.

Authors:  Christopher P Salas-Wright; Manuel Cano; James Hodges; Sehun Oh; Audrey Hang Hai; Michael G Vaughn
Journal:  Drug Alcohol Depend       Date:  2021-09-23       Impact factor: 4.492

7.  Fueled by an Epidemic: A Spatial Analysis of Opioid-Positive Drivers Fatally Injured in Motor Vehicle Collisions in West Virginia, 2011-2015.

Authors:  Toni M Rudisill
Journal:  Am J Public Health Res       Date:  2017-09-08

8.  The Effects of Acute Cannabis Use on Nontraffic Injury Risk: Reviewing the Available Literature and Identifying Ways Forward.

Authors:  Gabriel Andreuccetti; Yu Ye; Jaewook Kang; Rachael Korcha; Jane A Witbrodt; Heraclito B Carvalho; Cheryl J Cherpitel
Journal:  Contemp Drug Probl       Date:  2017-06-30

9.  Using Optimal Control to Disambiguate the Effect of Depression on Sensorimotor, Motivational and Goal-Setting Functions.

Authors:  He Huang; Katia Harlé; Javier Movellan; Martin Paulus
Journal:  PLoS One       Date:  2016-12-14       Impact factor: 3.240

10.  Alcohol and Road Traffic Injuries in Latin America and the Caribbean: A Case-Crossover Study.

Authors:  Guilherme Borges; Maristela Monteiro; Cheryl J Cherpitel; Ricardo Orozco; Yu Ye; Vladimir Poznyak; Margie Peden; Flavio Pechansky; Mariana Cremonte; Sandra D Reid; Jesus Mendez
Journal:  Alcohol Clin Exp Res       Date:  2017-09-13       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.